Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Glimiteris-MP2 Glimipiride, Pioglitazone & Metformin HCL Tablets:
Glimiteris-MP2 combines three active ingredientsGlimipiride, Pioglitazone, and Metformin HClinto a single tablet, providing an effective solution for managing type 2 diabetes. This combination therapy aims to achieve better blood glucose control and reduce the risk of diabetes-related complications.
Uses of Glimiteris-MP2 Glimipiride, Pioglitazone & Metformin HCL Tablets:
Glimiteris-MP2 is indicated for:
Management of type 2 diabetes mellitus in adults
Improvement of glycemic control in conjunction with diet and exercise
Treatment for patients who have not achieved adequate control with Metformin alone
Benefits of Glimiteris-MP2 Glimipiride, Pioglitazone & Metformin HCL Tablets:
Comprehensive glycemic control through a multifaceted approach
Reduces insulin resistance and enhances insulin secretion
Helps maintain optimal blood sugar levels throughout the day
Supports weight management and cardiovascular health
Mechanism of Action of Glimiteris-MP2 Glimipiride, Pioglitazone & Metformin HCL Tablets:
Glimepiride: A sulfonylurea that stimulates insulin release from the pancreas, thereby lowering blood sugar levels.
Pioglitazone: A thiazolidinedione that improves insulin sensitivity in muscle and fat tissues, facilitating better glucose utilization.
Metformin: A biguanide that decreases hepatic glucose production and increases insulin sensitivity, contributing to overall glycemic control.